Razelle Kurzrock: Target Cancer National Molecular Tumor Board

Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories shared a post on X:

“Target Cancer National Molecular Tumor Board. Bringing together experts across the country for the TRACK national precision medicine trial for rare cancers.

Thank you to an incredible group who give their time to help find solutions for patients with rare cancers.”